MAG-O3® Omega-3 mini
All the Benefits of Omega-3 in a Small, Easy-to-Swallow Capsule!
- 275 mg EPA · 125 mg DHA per mini softgel
- 800 mg EPA + DHA per serving of 2 mini softgels
- Patented monoglyceride form clinically studied in Quebec, Canada
- Mini format designed to be easy to swallow from age 9+
- Supports cognitive health and brain function
- Supports cardiovascular health in ages 13+
- Supports healthy development of the brain, eyes, and nerves in children aged 9–12
- No fishy aftertaste
- IFOS Certified
- NPN: 80140416
- Available in 60 or 120 mini softgels
- GTIN: 990312010302 / 990312010364
WHY A MINI FORMAT CHANGES EVERYTHING
The best omega-3 routine is the one you actually stick to.
For many people, the biggest barrier to omega-3s is not the science. It’s the size of the capsules.
MAG-O3® Omega-3 mini was designed to provide the same patented MAG-O3® monoglyceride technology in a smaller format that is easier to swallow and free from fishy aftertaste.
The result: a daily omega-3 that is easier to integrate for the whole family, starting at age 9.
The same MAG-O3®, in a smaller format
MAG-O3® Omega-3 mini uses the same patented monoglyceride oil and absorption technology as our other MAG-O3® formulas.
Smaller in size, without compromising quality, absorption, or EPA and DHA concentration.
An easier routine to maintain
With omega-3s, consistency matters.
A smaller, easy-to-swallow format with no fishy aftertaste helps turn omega-3 supplementation into a sustainable daily habit.
Comment fonctionne notre MAG-O3®
Une forme conçue pour être mieux absorbée. Les huiles de poisson conventionnelles doivent d’abord être digérées avant que les EPA et DHA puissent être absorbés.
MAG-O3® fournit les oméga-3 sous forme monoglycéride, une forme déjà pré-digérée et plus facilement absorbée par l’intestin.
Cette technologie permet de livrer davantage d’EPA et de DHA aux cellules, à dose égale.
How MAG-O3® Technology Works
A form designed for better absorption. Conventional fish oils must first be digested before EPA and DHA can be absorbed.
MAG-O3® delivers omega-3s in monoglyceride form, a pre-digested structure that is more easily absorbed by the intestine.
This technology helps deliver more EPA and DHA to cells, at the same dose, regardless of individual digestive capacity.
La recherche derrière MAG-O3® Oméga-3 mini
✔ Technologie canadienne brevetée
✔ Développée au Québec par Samuel Fortin, PhD
✔ Plus de 12 ans de recherche
✔ Études précliniques et cliniques publiées
✔ Étudié sur la biodisponibilité et l’Indice Oméga-3
Absorption supérieure observée
Dans un essai clinique publié, MAG-O3® Oméga-3 mini a livré
jusqu’à :
~3x plus d’EPA + DHA que les esters éthyliques (EE)
~2x plus que les triglycérides reconstitués (rTG)
à dose égale.
Indice Oméga-3 de 8 % atteint en 8 semaines
Dans l’étude IO3-03, MAG-O3® a permis d’atteindre le seuil cardiovasculaire de 8 % en seulement 8 semaines avec 1,3 g d’EPA + DHA par jour, alors que les groupes utilisant les formes esters éthyliques (EE) et triglycérides reconstitués (rTG) n’ont pas atteint ce seuil dans le même essai.
The Research Behind MAG-O3® Omega-3 mini
✔ Patented Canadian technology
✔ Developed in Quebec by Samuel Fortin, PhD
✔ More than 12 years of research
✔ Published preclinical and clinical studies
✔ Studied for bioavailability and Omega-3 Index support
Superior absorption observed
In a published clinical study, MAG-O3® Omega-3 mini delivered up to:
- ~3x more EPA + DHA than ethyl esters (EE)
- ~2x more than re-esterified triglycerides (rTG)
at the same dose.
8% Omega-3 Index reached in 8 weeks
In the IO3-03 study, MAG-O3® reached the cardiovascular Omega-3 Index threshold of 8% in just 8 weeks with 1.3 g EPA + DHA daily, while the ethyl ester (EE) and re-esterified triglyceride (rTG) groups did not reach this threshold within the same study.
All our MAG-O3™ products are IFOS certified.
Our MAG-O3® monoglyceride omega-3 products undergo rigorous testing and have received IFOS 5-Star certification, the highest international standard for fish oil purity, freshness, and potency.
Programme Santé Cellulaire EB Supplements
Phase I — Régulation (2 semaines)
- Fisétine+ Complexe Santé Cellulaire: Soutien inspiré de la recherche sur les composés sénolytiques.
Phase II — Protéger & Entretenir (8 à 12 semaines)
- Entretien Cellulaire + MAG-O3® Oméga-3 au Quotidien ou mini, avec ou sans MAG-EPA Concentré: Soutien du NAD+, de l’énergie cellulaire et de la santé des membranes.
Recommencer
Le programme est conçu pour être répété en cycles, avec un point de contrôle auprès d'un praticien de soins de santé au-delà de 12 semaines.
MAG-O3® Oméga-3 mini peut se prendre seul comme fondation oméga-3 quotidienne pour toute la famille, ou être combiné à MAG-O3® MAG-EPA Concentré selon vos besoins en EPA et DHA. Il constitue également une option pratique de la Phase II du Programme Santé Cellulaire EB Supplements grâce à son format mini facile à avaler.
EB Supplements Cellular Health Program
Phase I | Regulation (2 weeks)
- Fisetin+ Cellular Health Complex: Support inspired by research on senolytic compounds.
Phase II | Protect & Maintain (8 to 12 weeks)
- Cellular Maintenance + MAG-O3® Daily Omega-3 or mini, with or without MAG-EPA Concentrate: Support for NAD+, cellular energy, and membrane health.
Repeat
The program is designed to be repeated in cycles, with follow-up from a healthcare practitioner beyond 12 weeks when needed.
MAG-O3® Omega-3 mini can be taken alone as a daily omega-3 foundation for the whole family, or combined with MAG-O3® MAG-EPA Concentrate depending on your EPA and DHA needs.
It also serves as a practical Phase II option in the EB Supplements Cellular Health Program thanks to its easy-to-swallow mini format.
FAQ
Have a question that isn’t answered here? Write us, nous répondons à chaque message.
It’s exactly the same technology: patented MAG-O3® fish oil pre-digested monoglyceride form Norwegian fish oil IFOS 5-Star certification The difference is physical, not chemical. The mini softgel was designed to be smaller and easier to swallow, with a lower dose per capsule: 275 mg EPA 125 mg DHA At 2 mini softgels daily, you receive 800 mg EPA + DHA, a substantial daily omega-3 intake for the whole family.
From age 9 and up. Children and adolescents aged 9–17: 2 to 4 mini softgels daily with meals Adults 18+: 2 to 8 mini softgels daily with meals Always consult a healthcare professional before introducing a new supplement to a child.
Conventional fish oils — ethyl esters (EE) and triglycerides (TG) — must first be broken down by bile and pancreatic lipase before the small intestine can absorb the fatty acids. The MAG form is already pre-digested: one fatty acid attached to one glycerol backbone, ready for direct absorption. A published pharmacokinetic study associated the MAG form with: ~3x the plasma EPA response of EE omega-3s ~2x the response of re-esterified TG omega-3s (Chevalier et al., 2021)
The Canadian product license (NPN 80140416) recognizes three approved uses by age group:
- Ages 9+: Supports cognitive health and/or brain function.
- Children aged 9–12: Supports healthy development of the brain, eyes, and nerves.
- Adolescents and adults aged 13+: Supports cardiovascular health.
Per mini softgel 275 mg EPA 125 mg DHA 2 mini softgels daily 550 mg EPA 250 mg DHA 800 mg EPA + DHA total 4 mini softgels daily 1,100 mg EPA 500 mg DHA 1,600 mg EPA + DHA total 8 mini softgels daily (maximum adult dose) 2,200 mg EPA 1,000 mg DHA 3,200 mg EPA + DHA total
Two factors matter: concentration molecular form A standard 1,000 mg fish oil softgel typically contains: ~180 mg EPA ~120 mg DHA To reach 800 mg EPA + DHA, you would need to swallow 3–4 full-size capsules, and EE/TG absorption still remains below the MAG form. MAG-O3® Omega-3 mini combines concentration and optimized molecular delivery in a format everyone can swallow comfortably.
Omega-3 changes are biological, not stimulant-like. The Omega-3 Index typically changes measurably within 8–12 weeks of consistent daily use. Subjective effects such as: focus afternoon energy joint comfort sleep quality vary between individuals and tend to emerge gradually.
Yes. Each batch is independently tested through the International Fish Oil Standards (IFOS) program. MAG-O3® Omega-3 mini carries the IFOS 5-Star rating, the program’s highest certification level, evaluating: heavy metals PCBs dioxins label potency oxidation markers
Most users report little to no fish burps or fishy aftertaste, largely because of the physical behavior of the MAG-O3® monoglyceride form. Conventional hydrophobic fish oils float on stomach fluids, making reflux more noticeable. MAG-O3® is self-emulsifying, meaning it mixes with stomach fluids instead of floating on top. Combined with the freshness standards validated through IFOS oxidation testing, this helps minimize fishy aftertaste. Some sensitive individuals may still experience mild gastrointestinal effects, which are usually improved by taking the product with meals.
MAG-O3® fish oil is produced in Norway from small wild fish sourced from sustainable fisheries: anchovy sardine herring mackerel Each batch is certified: Friend of the Sea for sustainability IFOS 5-Star for purity, freshness, and potency
Yes. Like MAG-O3® Daily Omega-3, MAG-O3® Omega-3 mini serves as the daily omega-3 component of Phase II of the Cellular Health Program: Phase I: Fisetin+ (2 weeks) Phase II: Cellular Maintenance + omega-3 (8–12 weeks) The mini format is especially useful for family use or for individuals who prefer smaller softgels. Consult a healthcare practitioner for use beyond 12 weeks.